Free tool
FAERS Monitor: Zyvox
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021131 or its brand name (Zyvox, Linezolid). Reports on generic versions are filed under their own applications.
Reports
30,255
Serious
27,449
91% of reports
Hospitalization
12,516
Death reported
5,532
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use2,626
- thrombocytopenia2,242
- drug ineffective2,126
- anaemia1,777
- drug interaction1,460
- nausea1,450
- vomiting1,158
- platelet count decreased1,088
- diarrhoea1,084
- lactic acidosis1,040
- pyrexia1,039
- neuropathy peripheral1,019
- acute kidney injury962
- serotonin syndrome958
- pancytopenia936
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 326 |
| 2005 | 305 |
| 2006 | 546 |
| 2007 | 525 |
| 2008 | 439 |
| 2009 | 451 |
| 2010 | 897 |
| 2011 | 780 |
| 2012 | 690 |
| 2013 | 625 |
| 2014 | 563 |
| 2015 | 587 |
| 2016 | 951 |
| 2017 | 1,167 |
| 2018 | 2,670 |
| 2019 | 2,298 |
| 2020 | 2,380 |
| 2021 | 1,976 |
| 2022 | 2,407 |
| 2023 | 2,351 |
| 2024 | 2,577 |
| 2025 | 2,554 |
| 2026 | 2,190 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,023,904 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| serotonin syndromeSignal | 958 | 36.4 | 34.2 | 31,369 |
| lactic acidosisSignal | 1,040 | 23.0 | 21.7 | 21,224 |
| thrombocytopeniaSignal | 2,242 | 14.2 | 13.6 | 27,096 |
| pancytopeniaSignal | 936 | 11.8 | 11.1 | 9,133 |
| neuropathy peripheralSignal | 1,019 | 7.5 | 7.1 | 5,715 |
| platelet count decreasedSignal | 1,088 | 7.2 | 6.8 | 5,729 |
| anaemiaSignal | 1,777 | 6.5 | 6.2 | 8,312 |
| drug interactionSignal | 1,460 | 6.4 | 6.1 | 6,704 |
| acute kidney injurySignal | 962 | 4.4 | 4.1 | 2,519 |
| pyrexiaSignal | 1,039 | 2.1 | 2.0 | 598 |
| off label useSignal | 2,626 | 2.1 | 2.0 | 1,548 |
| vomiting | 1,158 | 1.7 | 1.6 | 351 |
| nausea | 1,450 | 1.3 | 1.2 | 88 |
| diarrhoea | 1,084 | 1.2 | 1.1 | 27 |
| drug ineffective | 2,126 | 1.1 | 1.1 | 30 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.